Impact BioMedical Inc.
IBO
$0.55
-$0.03-5.64%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.86M | -11.84M | -44.19M | -38.47M | -25.01M |
| Total Depreciation and Amortization | 1.43M | 1.15M | 862.00K | 8.00K | 7.00K |
| Total Amortization of Deferred Charges | 3.00K | -1.00K | 276.00K | 1.12M | 1.12M |
| Total Other Non-Cash Items | 9.36M | 8.20M | 40.43M | 34.51M | 21.44M |
| Change in Net Operating Assets | 684.00K | 600.00K | -353.00K | -534.00K | -603.00K |
| Cash from Operations | -1.67M | -1.89M | -2.98M | -3.36M | -3.05M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00K | 3.00K | 2.00K | 2.00K | 3.00K |
| Cash from Investing | 1.00K | 3.00K | 2.00K | 2.00K | 3.00K |
| Total Debt Issued | 666.00K | 184.00K | 317.00K | 257.00K | 641.00K |
| Total Debt Repaid | -293.00K | -293.00K | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 3.73M | 3.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 373.00K | -109.00K | 317.00K | 3.98M | 4.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.30M | -2.00M | -2.66M | 622.00K | 1.32M |